ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
|
|
Whitta
|
294 |
116K |
0 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
294
|
116K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Whitta
|
150 |
60K |
4 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
60K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM REPORTS IND APPLICATION UPDATE
|
|
Whitta
|
150 |
60K |
7 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
150
|
60K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Whitta
|
318 |
136K |
6 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
318
|
136K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Whitta
|
318 |
136K |
18 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
318
|
136K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
POST ANNOUNCEMENT DRINKS
|
|
Whitta
|
24 |
8.1K |
1 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
24
|
8.1K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where are PAR shareholders located?
|
|
Whitta
|
115 |
28K |
1 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
115
|
28K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
iPPS and the Cytokine
|
|
Whitta
|
12 |
4.4K |
6 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
12
|
4.4K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
3 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
3 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
1 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
1 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS
|
|
Whitta
|
52 |
21K |
2 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
52
|
21K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS
|
|
Whitta
|
52 |
21K |
11 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
52
|
21K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
0 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Passing the test and guess what, A Mozz Bonus
|
|
Whitta
|
9 |
3.4K |
7 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
9
|
3.4K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
8 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
The checklist and an Interview
|
|
Whitta
|
6 |
2.1K |
2 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
6
|
2.1K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Its a miracle
|
|
Whitta
|
13 |
4.4K |
2 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
13
|
4.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
5 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
2 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
17 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
17
|
|
ASX - By Stock
|
PAR |
Re:
PAR Clinical Trial - Melbourne
|
|
Whitta
|
69 |
25K |
5 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
69
|
25K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR Clinical Trial - Melbourne
|
|
Whitta
|
69 |
25K |
4 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
69
|
25K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR Clinical Trial - Melbourne
|
|
Whitta
|
69 |
25K |
6 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
69
|
25K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
1 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
1 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
0 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
0 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm doses first participant in Synovial Fluid Trial
|
|
Whitta
|
21 |
8.4K |
2 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
21
|
8.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Pirate Day Share Price 2021
|
|
Whitta
|
162 |
62K |
5 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
162
|
62K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm delivers IND to US FDA for Pivotal OA Program
|
|
Whitta
|
51 |
19K |
8 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
51
|
19K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Interview with Paul Rennie and Capital 51
|
|
Whitta
|
72 |
22K |
2 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
72
|
22K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Interview with Paul Rennie and Capital 51
|
|
Whitta
|
72 |
22K |
26 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
72
|
22K
|
26
|
|
ASX - By Stock
|
PAR |
Re:
Interview with Paul Rennie and Capital 51
|
|
Whitta
|
72 |
22K |
14 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
72
|
22K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Knee replacement surgery - innovative developments
|
|
Whitta
|
8 |
2.5K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
8
|
2.5K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
0 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
4 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Initial Director's Interest Notice
|
|
Whitta
|
3 |
1.8K |
0 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
3
|
1.8K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
A huge buying opportunity
|
|
Whitta
|
63 |
28K |
4 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
63
|
28K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Whitta
|
42 |
11K |
7 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
42
|
11K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Whitta
|
42 |
11K |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
42
|
11K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Whitta
|
42 |
11K |
4 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
42
|
11K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Trial PAR008 is on ANZCTR
|
|
Whitta
|
67 |
24K |
3 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
67
|
24K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Trial PAR008 is on ANZCTR
|
|
Whitta
|
67 |
24K |
2 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
67
|
24K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Whitta
|
4.2K |
3.8M |
6 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR CEO explains SAS patient results in interview
|
|
Whitta
|
35 |
11K |
5 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
35
|
11K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Whitta
|
4.1K |
1.9M |
1 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Consistent pain reduction and improvement in function data
|
|
Whitta
|
106 |
30K |
9 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
106
|
30K
|
9
|
|